Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date

Total article views   HTML views PDF downloads Totals
2,432 Dovepress* 2,232+ 635 2,867
PubMed Central* 200 62 262
Totals 2,432 697 3,129
*Since 25 September 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar